From population to neuron: exploring common mediators for metabolic problems and mental illnesses

The Danish Registry and its analysis

The Danish Civil Registration System covers all residents in Denmark and can identify individuals among all national registers, enabling precise linkage [15]. We used the Danish Psychiatric Registry containing all psychiatric hospitalizations since 1977 and all psychiatric contacts at outpatient services since 1995 [16], as well as the Danish National Diabetes Registry monitoring the occurrence of diabetes since 1995 [17]. All individuals who were alive in Denmark on January 1, 1997 were included in our study. This study was approved by the Danish Data Protection Agency, Statistics Denmark, and the Danish National Board of Health in which informed consent from each subject is not legally required for registry-based studies.

Psychiatric diagnosis was performed by psychiatrists who treated those individuals. The codes used to identify cohort members with SZ or BP and the criteria used to identify members with diabetes are summarized in Supplemental Tables 1 and 2, respectively. The incidence of the disease of interest (i.e., diabetes, SZ, or BP) in each population is summarized in Supplemental Table 3.

We used a log-linear Poisson regression with the GENMOD procedure using the SAS program (version 9.2, SAS Institute, Inc.). This method estimates a Cox regression, and calculates the incidence rate that is described as relative risk (RR). RRs were adjusted for the following potential confounders: calendar year, age group, gender, parental family history of SZ, parental family history of BP, parental family history of diabetes, history of alcohol abuse, and degree of urbanicity at birth. Degree of urbanization was defined as Capital, Capital Suburb, Provincial City, Provincial Town, and Rural Area. Age, calendar year, psychiatric diagnosis, and diagnosis of diabetes were treated as time-dependent variables, while all others were treated as fixed variables. Age was categorized into 10-year intervals. Calendar year was categorized into 1-year intervals for 1997 and into 2-year intervals thereafter. We included only persons aged 15 years or older when analyzing the risk of major mental illnesses in the diabetic population, since the incidence of SZ and BP is very small in children younger than that age. We also linked the data to the Danish National Registry of Patients for additional analyses to examine potential confounding by differences in the subtypes of diabetes (i.e., types 1 and 2). We used the subdivision of diabetes only for supplemental analyses, because although the diagnosis in the Danish National Registry of Patients is based on the Danish version of the World Health Organization International Classification of Diseases, tenth edition (ICD 10), other indicators for the diagnosis of type 1 diabetes (e.g., immunological tests) were not considered.

Analysis of gene expression in human olfactory neuronal cells (the PsychENCODE dataset)

We conducted literature mining of the genes that were differentially expressed between SZ patients and healthy controls (FDR < 0.05) in olfactory neuronal cells in the PsychENCODE dataset [18]. Genes were annotated either insulin-related or -unrelated based on the criteria that more than 100 publications mentioned its gene symbol and insulin at the same time in the title or abstract in PubMed publications. NCBI Entrez Programming Utilities (E-utilities) was used to perform a batch search for all human genes. Chi-square test for the following 2×2 contingency table was performed to evaluate whether or not insulin-related genes were enriched in these differentially expressed genes.

Analysis of IRS1/2 phosphorylation in human olfactory neuronal cells (the Johns Hopkins cohort)

In the Johns Hopkins Schizophrenia Center, olfactory neuronal cells were prepared from nasal biopsied tissues from patients and healthy controls, according to published protocols [19, 20]. In the present study, we used neuronal cells from patients with SZ (N=15), BP (N=11), and healthy control subjects (N=15). Due to vulnerability of these primary cells to freeze-thaw process, cells from 1 heathy control and 2 SZ were not available in the experiments for IRS1. These patients were drawn from the clinical population at the Johns Hopkins Medical Institutions. Healthy controls were recruited through advertisements placed in local papers or leaflets left on hospital boards. All subjects gave informed consent that had been approved by the Johns Hopkins Hospital IRB.

To examine the cellular response to insulin, we used a published protocol with some modifications [21]. In brief, following serum starvation for 48 h in D-MEM/F-12 medium (Invitrogen), the cells were stimulated for 10 min with 10 nM of insulin (Sigma) before being harvested. The level of phospho-IRS2 was assessed by immuno-precipitation followed by Western blotting, according to an established protocol with some modifications [21-23]. In brief, cells were lysed with RIPA buffer (Cell Signaling Technologies) together with protease inhibitors (cOmplete; Roche) and phosphatase inhibitors (Thermo Scientific). Cell supernatant obtained by centrifugation at 15,000 rpm for 20 min at 4°C was used for immunoprecipitation with an anti-IRS2 antibody (Cell Signaling Technologies). Immunoprecipitates were analyzed by SDS-PAGE followed by Western blotting with an anti-pan phospho-tyrosine antibody, 4G10 (Millipore). The level of phospho-IRS1 was assessed by Western blotting with an anti-phospho-IRS1 (at human serine-312) antibody (Cell Signaling Technologies). Cell supernatant was obtained by the same protocol as used for the IRS2 experiments.

Signal detection was carried out with LAS 1000, and the signal intensity was quantified with Image J software. Statistical analysis was performed using one-way analysis of variance (ANOVA) with Bonferroni’s multiple comparison test or Kruskal-Wallis analysis followed by Dunn’s test.

Behavioral studies of Irs2 knockout mice

Irs2 knockout (KO) mice have been described previously [24]. Mice were maintained at the Medical Innovation Center of Kyoto University Graduate School of Medicine with the C57Bl6/J genetic background by mating heterozygotes. All mice were group housed after weaning and throughout the behavioral testing, and kept under a 12 h light /12 h dark cycle with food and water provided ad lib. We used male homozygous (KO) mice and their wild type (WT) littermates for analysis. We followed the sample size and behavioral assay protocols in our past publications [20, 25-28].

We used two cohorts: For the first cohort, the following behavioral tests were performed day by day in 7 weeks of age: weight check and open field; Y-maze; three-chamber social interaction; elevated plus maze; forced swim; and weight check and rotarod. The second cohort was used for methamphetamine challenge (postnatal days 48-52): we measured their body weight and performed open field for the first 60 min following an intraperitoneal saline injection, and then for another 120 min following an intraperitoneal methamphetamine injection (1 mg/kg). Using total distance traveled during the last 10 min before methamphetamine injection as baseline, we assessed the fold change relative to the baseline activity after methamphetamine injection [29]. Behaviors were recorded and analyzed automatically to keep objectiveness.

All data are presented as the mean with standard error of the mean. Statistical analysis was performed using univariate or repeated measures ANOVA, or F-test with either Student’s t or Welch’s t test. For measurements of methamphetamine-induced hyperactivity, statistical significance was determined using two-way ANOVA and subsequent Sidak’s post hoc analysis for multiple comparisons.

Higher risk of developing diabetes after the onset of major mental illnesses (SZ and BP)

First, we addressed whether patients diagnosed with SZ or BP have a higher risk of later developing diabetes compared with the general population. We took advantage of the Danish Civil Registration System that enabled us to follow individuals with diseases of interest in the entire Danish population. We linked the registers in the Danish Psychiatric Registry with those in the Danish National Diabetes Registry, both described in detail in the section on Materials and Methods. We performed a prospective study from January 1, 1997 to one of the following time points: onset of the disease of interest, relocation out of Denmark, or December 31, 2009, whichever came earliest.

We compared the incidence of diabetes among four groups, namely subjects with SZ, without SZ, with BP, and without BP, as rate per 1000 person-years (Supplemental Table 3a). Then, we calculated the incidence-rate ratios between groups with and without disorders, which could be interpreted as the RR for the disorders. Analyses showed that the incidence of diabetes was higher in both patients with SZ [adjusted RR = 2.16, 95% confidence interval (CI) = 2.03-2.29 for female, adjusted RR = 1.78, 95% CI = 1.68-1.88 for male] and patients with BP (adjusted RR = 1.63, 95% CI = 1.53-1.74 for female, adjusted RR = 1.36, 95% CI = 1.26-1.48 for male) compared with the general population (Fig. 1a). The full models of the log linear regression analyses are summarized in Tables 1a and 1b. These are consistent with several previous reports [6-9]. Although women were less likely to develop diabetes than men in the population registered in the depository (adjusted RR = 0.83, 95% CI = 0.82-0.84), women were at higher risk of developing diabetes when they also had SZ or BP.

• Download figure
• Open in new tab

Fig. 1 Relations between risk of diabetes and severe mental illnesses

(a) The risk of diabetes in patients with schizophrenia (SZ) and bipolar disorder (BP) is estimated by analysis of the National Registry in Denmark. Lines indicate relative risk, and bars indicate ranges with 95% confidence interval (CI). Data are shown separately for each gender. Females showed higher incidence of SZ and BP than males in the National Registry.

(b) The risk of SZ and BP in patients with diabetes is estimated by analysis of the National Registry in Denmark. Lines indicate relative risk, and bars indicate ranges with 95% CI. Data are shown separately for each gender. Note that there is no gender difference in the incidence of diabetes in the National Registry.

Higher risk of developing major mental illnesses (SZ and BP) after the onset of diabetes

We next addressed the risk of developing (or diagnosed with) SZ or BP between patients with diabetes and the general population (Supplemental Tables 3b and 3c). We employed the same strategy that was used to validate higher risk of developing diabetes after the onset of SZ or BP.

We observed an increased risk of developing SZ or BP in the diabetic population compared to the general population (for SZ, adjusted RR = 1.95, 95% CI = 1.62-2.35 for female, adjusted RR = 1.63, 95% CI = 1.33-1.99 for male; for BP, adjusted RR = 1.39, 95 % CI = 1.19-1.62 for female, adjusted RR = 1.41, 95% CI = 1.21-1.66 for male) (Fig. 1b). The full models of the regression analyses are summarized in Tables 2a and 2b. In the registered population, women had a higher risk of developing both SZ (adjusted RR = 2.61, 95% CI = 1.74-3.89) and BP (adjusted RR = 1.50, 95% CI = 1.26-1.79) than men. Women with diabetes also had a higher risk of developing SZ, but not BP, than men.

The Diabetes Registry does not subdivide diabetes types 1 and 2, but the Danish National Registry of Patients does make that distinction. Therefore we further analyzed the data as follows: 1) we excluded diabetic patients who had a diagnosis of type 1 in the Danish National Registry of Patients and calculated the risk of type 2 diabetes in patients with SZ and BP: 2) then we examined the risk of developing SZ or BP in patients with each type of diabetes based on the Danish National Registry of Patients. These additional analyses did show the bi-directional association between major mental disorders and type 2 diabetes in the same cohort (Supplemental Tables 4-6). Therefore, our main results shown above likely reflect an association between type 2 diabetes and major mental illnesses. From a biological viewpoint, this epidemiological data suggest the existence of common pathophysiological mediators in both diabetes and major mental illnesses.

Evidence of aberrant insulin signaling and insulin resistance in olfactory neuronal cells biopsied from patients with major mental illnesses (SZ and BP)

As described above, we successfully observed a bi-directional relationship between diagnoses with type 2 diabetes and major mental illnesses in the same cohort (Fig. 1). Thus, we hypothesized that common mediators or drivers might underlie both metabolic and mental disorders to explain the bi-directional relationship. To address this question, we used olfactory neuronal cells biopsied from living patients with SZ and BP, as well as those from healthy controls. Olfactory neuronal cells may be a good surrogate tissue to capture neuronal molecular/biological changes associated with disease “pathophysiology”, because these cells are directly used after biopsy from patients and healthy controls without any genetic manipulation or reprogramming [18-20, 30-32]. Olfactory neuronal cells are prepared near to homogeneity [19] and expected to reflect molecular signatures of “pathophysiology”, a converged outcome of genetic and environmental interactions as well as associated stressors [18, 19, 32]. These cells are different from iPS cells from which we expect disease- and individual-associated trait changes (e.g., genetic impacts) related to the disease “pathogenesis” on cellular phenotypes. In the present study, we used two independent sets of data from olfactory neuronal cells.

First, we used the RNA-seq expression profile dataset provided by PsychENCODE [18, 31]. In the study, 36 genes were underscored as differentially expressed (FDR < 0.05) between SZ patients and healthy controls. According to the criteria described in the Method section, we annotated the differentially expressed genes and non-differentially expressed genes into either insulin-related or -unrelated. Among 36 differentially expressed genes, 4 genes (11%) were insulin-related, whereas only 358 genes (1.5%) were insulin-related out of 23,526 genes whose expressions were not significantly different between SZ patients and healthy controls (Supplemental Table 7). Thus, in differentially expressed genes between SZ and healthy controls, a significant enrichment of insulin-related genes was indeed validated in olfactory neuronal cells (P = 5.4E-05). These data further support the idea that aberrant insulin signaling may be involved in the pathophysiology of SZ.

Second, we further hypothesized that aberrant insulin signaling may be represented by a hallmark of insulin resistance in olfactory neuronal cells in major mental illnesses, such as SZ. Tyrosine phosphorylation of IRS2 is regarded as a key molecular signature to represent the integrated insulin response [33, 34]: reduction in the level of tyrosine phosphorylation of IRS2 in response to insulin is a well-known indicator of insulin resistance, and a fundamental pathophysiology of type 2 diabetes [35]. Meanwhile, insulin/IRS2 play a key role in cognitive and mental function, in conjunction with their downstream signaling cascades, such as Akt [36, 37]. As far as we are aware, no direct study of IRS2 phosphorylation has been performed using tissue from patients with SZ and BP. Thus, by using olfactory neuronal cells we asked whether a reduction in IRS2 phosphorylation might underlie both diabetes and major mental illnesses (SZ and BP). In this protein study, we used olfactory neuronal cells that were collected at the Johns Hopkins Schizophrenia Center (Supplemental Table 8; also see the Method section).

To examine the cellular response of olfactory neuronal cells to insulin, cells were stimulated with insulin and the relative level of the specific phosphorylation of IRS2 to the overall expression of IRS2 protein was assessed by immunoprecipitation followed by Western blotting (IP-Western) (Supplemental Fig. 1) As shown in Fig. 2, insulin-stimulated tyrosine phosphorylation of IRS2 was significantly decreased in SZ patient-derived olfactory neuronal cells (about 50% of controls). A consistent trend of reduction was also found in BP patient-derived cells (about 75% of controls). Furthermore, we excluded one SZ patient who was pre-diabetic and 2 BP patients who had diabetes at the time of the nasal biopsy, and conducted the same analysis: the new results without these 3 pre-diabetic and diabetic subjects lead to the same conclusions as those we obtained from the analysis that included all subjects (Supplemental Fig. 2). Removal of one possible outlier (higher than the average at more than two-fold standard deviation) from the healthy control group did not affect the significant difference between SZ patients and healthy controls (Supplemental Fig. 3). The fact that neuronal cells derived from patients with SZ or BP responded poorly to insulin stimulation, a characteristic also observed in subjects with insulin resistance, suggested that common molecular mediators involving insulin/IRS2 signaling might underlie both diabetes and major mental illnesses.

• Download figure
• Open in new tab

Fig. 2 Tyrosine phosphorylation of IRS2 in olfactory neuronal cells derived from SZ and BP patients

Olfactory neuronal cells derived from patients with SZ or BP as well as those from healthy controls (HC) were stimulated with insulin and characterized for the level of tyrosine phosphorylation of IRS2. Data are shown as mean ± SEM. * P<0.013. Red, 1 SZ patient who was pre-diabetic and 2 BP patients who had diabetes at the time of the nasal biopsy. Blue, an outlier that is different from the average at more than two-fold the standard deviation. Notes: the data in the case when we removed the 3 patients in pre-diabetic or diabetic condition are shown in Supplemental Fig. 2. Furthermore, the data in the case we removed the outlier are shown in Supplemental Fig. 3. In both cases, the scientific conclusions are the same.

A previous report with animal models indicated that phosphorylation of IRS1 at serine 307 was upregulated in an insulin resistance condition at baseline (without insulin stimulation) in vivo [38]. Thus, we tested the phosphorylation of serine 312 (the equivalent residue in humans to mouse serine 307) and observed that IRS1 phosphorylation at serine 312 was upregulated at baseline (without insulin stimulation) in olfactory neuronal cells from SZ patients, compared with controls (Supplemental Fig. 4), whereas no difference was observed between BP patients and controls. Taken together, molecular signatures of insulin resistance were observed in both IRS1 and IRS2 in neuronal cells from SZ patients, and those also observed at least in IRS2 in neuronal cells from BP patients.

Dopamine-associated behavioral changes in Irs2 knockout (KO) mice

Next we explored these putative common mediators (e.g., IRS2 and IRS1) in higher brain function relevant to major mental illnesses by using a genetically engineered model. As the first step of a long-term effort in addressing the mechanism, we decided to address a loss of function of IRS2. We selected IRS2 as the first target since IRS2 is more thoroughly studied in the brain compared with IRS1 [20, 36, 37, 39]: nevertheless, its investigation has not yet extended to the biology of mental disorders. Thus, we examined behavioral changes relevant to major mental illnesses in Irs2 knockout mice (KO). In order to avoid the potential complications of premature death due to excessive hyperglycemia [35, 40], we used male KO animals at 7 weeks of age (late adolescence to young adulthood) for our analysis. Due to deficits in motor function observed in the rotarod paradigm (Supplemental Fig. 5a), the interpretation of experimental results was not straightforward. For example, KO mice showed decreased spontaneous activity in the open field, as well as total distance in the elevated plus maze and Y-maze tasks, which may possibly be associated with motor deficits (Supplemental Fig. 5b-d). We did not observe any significant difference between WT and KO mice in the three chamber social interaction tasks (Supplemental Fig. 5e). In contrast, Irs2 KO mice showed increased immobility in the forced swim test (Supplemental Fig. 5f). This finding may be indicative of depression-associated changes, consistent with human findings that individuals with diabetes have an elevated risk for depression [41]. Nevertheless, we cannot fully exclude the possibility that this result is due to impaired motor function.

Because the deficits in motor function are a potential confound in the interpretation of the data, we introduced a challenge study using the psychostimulant, methamphetamine, to address neurochemical changes in vivo. Patients with psychotic disorders are known to show hypersensitivity to psychostimulants such as methamphetamine [42], and such pathophysiology has been studied in mouse models as a relative increase in locomotion compared to baseline (before psychostimulant administration) [43]. Interestingly, KO mice showed a significantly greater response to methamphetamine compared to WT mice (Fig. 3). We observed two peaks of augmented responses to methamphetamine in KO mice, which is not usually seen in WT mice.

• Download figure
• Open in new tab

Fig. 3 Response of Irs2 knockout mice after methamphetamine administration

A methamphetamine challenge test was conducted in 10 wild type (WT) and 9 knockout (KO) mice. The fold change in the total distance traveled every 10 min after methamphetamine injection relative to baseline activity is demonstrated. Data are shown as mean ± SEM. * P<0.05, ** P<0.01.